

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.49273176 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.49273176 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.19171976 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.19171976 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.99396607 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.47057000 |
| 7 | high-density lipoprotein particle remodeling (GO:0034375) | 6.15921814 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 6.15845761 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 6.05323073 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.82067005 |
| 11 | regulation of fibrinolysis (GO:0051917) | 5.74417823 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.62130092 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.55548178 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.55548178 |
| 15 | tryptophan catabolic process (GO:0006569) | 5.55548178 |
| 16 | reverse cholesterol transport (GO:0043691) | 5.54563939 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51855779 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.49546367 |
| 19 | protein carboxylation (GO:0018214) | 5.49546367 |
| 20 | bile acid biosynthetic process (GO:0006699) | 5.47516186 |
| 21 | urea cycle (GO:0000050) | 5.41426928 |
| 22 | urea metabolic process (GO:0019627) | 5.41426928 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.36583760 |
| 24 | tryptophan metabolic process (GO:0006568) | 5.30744857 |
| 25 | cysteine metabolic process (GO:0006534) | 5.29085291 |
| 26 | regulation of cholesterol esterification (GO:0010872) | 5.27808901 |
| 27 | omega-hydroxylase P450 pathway (GO:0097267) | 5.25046117 |
| 28 | plasma lipoprotein particle remodeling (GO:0034369) | 5.21261299 |
| 29 | protein-lipid complex remodeling (GO:0034368) | 5.21261299 |
| 30 | macromolecular complex remodeling (GO:0034367) | 5.21261299 |
| 31 | exogenous drug catabolic process (GO:0042738) | 5.14553778 |
| 32 | phospholipid efflux (GO:0033700) | 5.04645291 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.01118479 |
| 34 | negative regulation of cholesterol transport (GO:0032375) | 4.99310339 |
| 35 | negative regulation of sterol transport (GO:0032372) | 4.99310339 |
| 36 | plasma lipoprotein particle clearance (GO:0034381) | 4.95244892 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.94543062 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.91062300 |
| 39 | bile acid metabolic process (GO:0008206) | 4.88541332 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.80838277 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.73528347 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.73528347 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.70205498 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.68060992 |
| 45 | complement activation, alternative pathway (GO:0006957) | 4.66330204 |
| 46 | lysine catabolic process (GO:0006554) | 4.66185575 |
| 47 | lysine metabolic process (GO:0006553) | 4.66185575 |
| 48 | negative regulation of protein activation cascade (GO:2000258) | 4.64350426 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 4.61047997 |
| 50 | cholesterol efflux (GO:0033344) | 4.60567931 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.57584601 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.57493239 |
| 53 | glycine metabolic process (GO:0006544) | 4.56079792 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.55863308 |
| 55 | negative regulation of hemostasis (GO:1900047) | 4.53947045 |
| 56 | negative regulation of blood coagulation (GO:0030195) | 4.53947045 |
| 57 | plasma lipoprotein particle assembly (GO:0034377) | 4.52859592 |
| 58 | phenylpropanoid metabolic process (GO:0009698) | 4.51173210 |
| 59 | regulation of complement activation (GO:0030449) | 4.49888783 |
| 60 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.48693142 |
| 61 | protein activation cascade (GO:0072376) | 4.44285485 |
| 62 | proline metabolic process (GO:0006560) | 4.43784335 |
| 63 | serine family amino acid biosynthetic process (GO:0009070) | 4.33179594 |
| 64 | glutamate metabolic process (GO:0006536) | 4.31390095 |
| 65 | acute-phase response (GO:0006953) | 4.26992542 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.26492745 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.26474897 |
| 68 | low-density lipoprotein particle remodeling (GO:0034374) | 4.25548096 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.22062480 |
| 70 | drug catabolic process (GO:0042737) | 4.21656975 |
| 71 | negative regulation of coagulation (GO:0050819) | 4.14413829 |
| 72 | bile acid and bile salt transport (GO:0015721) | 4.13743013 |
| 73 | regulation of humoral immune response (GO:0002920) | 4.11880368 |
| 74 | fibrinolysis (GO:0042730) | 4.10697920 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 4.09859074 |
| 76 | cellular glucuronidation (GO:0052695) | 4.08914248 |
| 77 | protein-lipid complex assembly (GO:0065005) | 4.07522848 |
| 78 | positive regulation of hemostasis (GO:1900048) | 4.06516243 |
| 79 | positive regulation of blood coagulation (GO:0030194) | 4.06516243 |
| 80 | negative regulation of complement activation (GO:0045916) | 4.06503738 |
| 81 | negative regulation of wound healing (GO:0061045) | 4.04628971 |
| 82 | cholesterol homeostasis (GO:0042632) | 4.03068163 |
| 83 | ethanol metabolic process (GO:0006067) | 4.02896250 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.01907147 |
| 85 | complement activation, classical pathway (GO:0006958) | 4.01038121 |
| 86 | plasma lipoprotein particle organization (GO:0071827) | 4.00586244 |
| 87 | aldehyde catabolic process (GO:0046185) | 3.98518266 |
| 88 | ketone body metabolic process (GO:1902224) | 3.97870632 |
| 89 | sterol homeostasis (GO:0055092) | 3.96923594 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.95819445 |
| 91 | indolalkylamine metabolic process (GO:0006586) | 3.95480963 |
| 92 | arginine metabolic process (GO:0006525) | 3.95416415 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.93983511 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.93641176 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.93641176 |
| 96 | coenzyme catabolic process (GO:0009109) | 3.92307579 |
| 97 | blood coagulation, intrinsic pathway (GO:0007597) | 3.92168797 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.91896348 |
| 99 | oxidative demethylation (GO:0070989) | 3.88497465 |
| 100 | ethanol oxidation (GO:0006069) | 3.87878609 |
| 101 | complement activation (GO:0006956) | 3.87834820 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.86521643 |
| 103 | regulation of apoptotic cell clearance (GO:2000425) | 3.85872168 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.83905876 |
| 105 | intestinal cholesterol absorption (GO:0030299) | 3.82186795 |
| 106 | short-chain fatty acid metabolic process (GO:0046459) | 3.81479602 |
| 107 | cellular biogenic amine catabolic process (GO:0042402) | 3.81234979 |
| 108 | amine catabolic process (GO:0009310) | 3.81234979 |
| 109 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.78695439 |
| 110 | positive regulation of coagulation (GO:0050820) | 3.78337747 |
| 111 | protein-lipid complex subunit organization (GO:0071825) | 3.77634157 |
| 112 | lipoprotein metabolic process (GO:0042157) | 3.77346248 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.71125925 |
| 114 | cofactor catabolic process (GO:0051187) | 3.70442246 |
| 115 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69646284 |
| 116 | organic acid catabolic process (GO:0016054) | 3.68537436 |
| 117 | carboxylic acid catabolic process (GO:0046395) | 3.68537436 |
| 118 | aspartate family amino acid catabolic process (GO:0009068) | 3.65418677 |
| 119 | uronic acid metabolic process (GO:0006063) | 3.63995709 |
| 120 | glucuronate metabolic process (GO:0019585) | 3.63995709 |
| 121 | regulation of plasminogen activation (GO:0010755) | 3.60735827 |
| 122 | flavonoid metabolic process (GO:0009812) | 3.59057375 |
| 123 | drug metabolic process (GO:0017144) | 3.56557212 |
| 124 | regulation of lipoprotein particle clearance (GO:0010984) | 3.55694538 |
| 125 | acute inflammatory response (GO:0002526) | 3.51851607 |
| 126 | cytolysis (GO:0019835) | 3.42297095 |
| 127 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.18348811 |
| 128 | sterol transport (GO:0015918) | 3.18339001 |
| 129 | cholesterol transport (GO:0030301) | 3.18339001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38398661 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.25531468 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.56281248 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.50309077 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.13573221 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.05012323 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.96987815 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.92869483 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.80255348 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21990211 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05623010 |
| 12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0857247 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99650281 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96030797 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.84758795 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66368677 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52250428 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51533145 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43885019 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42823318 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.36547650 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29911000 |
| 23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29448849 |
| 24 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28992022 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20546331 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17923446 |
| 27 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17777482 |
| 28 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.17717332 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17430554 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15691834 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14371381 |
| 32 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13073564 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11208106 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03598860 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02747196 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01893927 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.01368396 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01250722 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95958332 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95942422 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95688593 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90269069 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88474805 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86630665 |
| 45 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85847831 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85504047 |
| 47 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84175025 |
| 48 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83971257 |
| 49 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83649951 |
| 50 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83112340 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82030939 |
| 52 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.81813244 |
| 53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81367332 |
| 54 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81153598 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80490957 |
| 56 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79763291 |
| 57 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79658142 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78155608 |
| 59 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77484706 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76873198 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76532115 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76457463 |
| 63 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.76103876 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.73785061 |
| 65 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72318841 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.71564514 |
| 67 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69386449 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.68506941 |
| 69 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.67821664 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.67712797 |
| 71 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.67509667 |
| 72 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66680525 |
| 73 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65013780 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62287218 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.61486509 |
| 76 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.61065308 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.60959350 |
| 78 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.59922022 |
| 79 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59581229 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.59177823 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.59083835 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.58821605 |
| 83 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.58686821 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57780783 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 0.57345027 |
| 86 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.57159661 |
| 87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57028460 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.56987656 |
| 89 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56573788 |
| 90 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.56285096 |
| 91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.56193985 |
| 92 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56177058 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55271071 |
| 94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.55114842 |
| 95 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.54524651 |
| 96 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54443906 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54423380 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53777782 |
| 99 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.53655034 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 0.53306624 |
| 101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.52988757 |
| 102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.52675896 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.52585798 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.52093526 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51662225 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.50328393 |
| 107 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.49079610 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.49057138 |
| 109 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48732781 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46725325 |
| 111 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46361419 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45513828 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.45102166 |
| 114 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.44485534 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.44482892 |
| 116 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44186546 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.43407515 |
| 118 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43353438 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42452107 |
| 120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.41983664 |
| 121 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.41964817 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.41957882 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.41957882 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41286427 |
| 125 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.40979726 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40945283 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40919296 |
| 128 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.40472003 |
| 129 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40050413 |
| 130 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39465260 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39014388 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.38862667 |
| 133 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.38224765 |
| 134 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.38196390 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38157063 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.38119687 |
| 137 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37560883 |
| 138 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.37529171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.15892941 |
| 2 | MP0005360_urolithiasis | 7.11507537 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.37106377 |
| 4 | MP0005365_abnormal_bile_salt | 6.16695494 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.97213153 |
| 6 | MP0005083_abnormal_biliary_tract | 4.37829855 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.05806345 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.77132053 |
| 9 | MP0003252_abnormal_bile_duct | 3.71806760 |
| 10 | MP0009840_abnormal_foam_cell | 3.31514610 |
| 11 | MP0001666_abnormal_nutrient_absorption | 3.13346086 |
| 12 | MP0005332_abnormal_amino_acid | 2.66241639 |
| 13 | MP0003195_calcinosis | 2.56423835 |
| 14 | MP0003868_abnormal_feces_composition | 2.40794030 |
| 15 | MP0001346_abnormal_lacrimal_gland | 2.31941531 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.20899515 |
| 17 | MP0005379_endocrine/exocrine_gland_phen | 2.13608126 |
| 18 | MP0000609_abnormal_liver_physiology | 2.12267011 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.09843788 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.97294902 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.78282538 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.73393875 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 1.56320159 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.52803398 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.51193749 |
| 26 | MP0005451_abnormal_body_composition | 1.49467357 |
| 27 | MP0009697_abnormal_copulation | 1.48410616 |
| 28 | MP0001764_abnormal_homeostasis | 1.47376501 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46515518 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.45040581 |
| 31 | MP0002132_abnormal_respiratory_system | 1.32744631 |
| 32 | MP0001919_abnormal_reproductive_system | 1.30909211 |
| 33 | MP0000566_synostosis | 1.26984878 |
| 34 | MP0005220_abnormal_exocrine_pancreas | 1.26579270 |
| 35 | MP0003011_delayed_dark_adaptation | 1.26521569 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.25567577 |
| 37 | MP0000598_abnormal_liver_morphology | 1.21352082 |
| 38 | MP0002089_abnormal_postnatal_growth/wei | 1.15901113 |
| 39 | MP0003186_abnormal_redox_activity | 1.13451794 |
| 40 | MP0001881_abnormal_mammary_gland | 1.10586083 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.10278036 |
| 42 | MP0000604_amyloidosis | 1.09799172 |
| 43 | MP0010368_abnormal_lymphatic_system | 1.04649331 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.03965014 |
| 45 | MP0004233_abnormal_muscle_weight | 1.03673343 |
| 46 | MP0003172_abnormal_lysosome_physiology | 0.99926440 |
| 47 | MP0005408_hypopigmentation | 0.97441312 |
| 48 | MP0002282_abnormal_trachea_morphology | 0.97437317 |
| 49 | MP0009763_increased_sensitivity_to | 0.95253044 |
| 50 | MP0002254_reproductive_system_inflammat | 0.94491151 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 0.87445588 |
| 52 | MP0005647_abnormal_sex_gland | 0.85419098 |
| 53 | MP0009764_decreased_sensitivity_to | 0.84535681 |
| 54 | * MP0009642_abnormal_blood_homeostasis | 0.84059899 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.80786472 |
| 56 | MP0002909_abnormal_adrenal_gland | 0.80297237 |
| 57 | MP0005389_reproductive_system_phenotype | 0.78860534 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 0.76745742 |
| 59 | MP0009053_abnormal_anal_canal | 0.74915557 |
| 60 | MP0002098_abnormal_vibrissa_morphology | 0.74607840 |
| 61 | MP0009672_abnormal_birth_weight | 0.74386460 |
| 62 | * MP0008469_abnormal_protein_level | 0.74327488 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.73694662 |
| 64 | MP0005376_homeostasis/metabolism_phenot | 0.71706391 |
| 65 | MP0003329_amyloid_beta_deposits | 0.70020188 |
| 66 | MP0000627_abnormal_mammary_gland | 0.69631168 |
| 67 | MP0000427_abnormal_hair_cycle | 0.69043196 |
| 68 | MP0005334_abnormal_fat_pad | 0.68944247 |
| 69 | MP0003941_abnormal_skin_development | 0.66501286 |
| 70 | MP0004130_abnormal_muscle_cell | 0.66417158 |
| 71 | MP0000639_abnormal_adrenal_gland | 0.65858451 |
| 72 | MP0009384_cardiac_valve_regurgitation | 0.65805857 |
| 73 | MP0003879_abnormal_hair_cell | 0.65429666 |
| 74 | MP0002168_other_aberrant_phenotype | 0.61954906 |
| 75 | MP0003122_maternal_imprinting | 0.61480654 |
| 76 | MP0002971_abnormal_brown_adipose | 0.61242182 |
| 77 | MP0002876_abnormal_thyroid_physiology | 0.60097966 |
| 78 | MP0001756_abnormal_urination | 0.60083547 |
| 79 | MP0005448_abnormal_energy_balance | 0.59497896 |
| 80 | MP0003690_abnormal_glial_cell | 0.58997442 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 0.57373646 |
| 82 | MP0005535_abnormal_body_temperature | 0.56805799 |
| 83 | MP0002928_abnormal_bile_duct | 0.55757529 |
| 84 | MP0005266_abnormal_metabolism | 0.55041455 |
| 85 | MP0000681_abnormal_thyroid_gland | 0.54042486 |
| 86 | MP0001661_extended_life_span | 0.53269658 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.52171236 |
| 88 | MP0002090_abnormal_vision | 0.51128015 |
| 89 | MP0005464_abnormal_platelet_physiology | 0.49275528 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.49167014 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.48803305 |
| 92 | MP0001944_abnormal_pancreas_morphology | 0.47316826 |
| 93 | MP0005409_darkened_coat_color | 0.44643037 |
| 94 | MP0005670_abnormal_white_adipose | 0.44054232 |
| 95 | MP0005164_abnormal_response_to | 0.43864727 |
| 96 | MP0008872_abnormal_physiological_respon | 0.42797157 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.42456630 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.41339851 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.41335928 |
| 100 | MP0008873_increased_physiological_sensi | 0.38674146 |
| 101 | MP0005395_other_phenotype | 0.37334570 |
| 102 | MP0008874_decreased_physiological_sensi | 0.37198940 |
| 103 | MP0003718_maternal_effect | 0.37037798 |
| 104 | * MP0003953_abnormal_hormone_level | 0.37005935 |
| 105 | MP0006035_abnormal_mitochondrial_morpho | 0.36434086 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.36353008 |
| 107 | MP0009115_abnormal_fat_cell | 0.36350345 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.36331284 |
| 109 | MP0003123_paternal_imprinting | 0.35841077 |
| 110 | MP0001243_abnormal_dermal_layer | 0.35650573 |
| 111 | MP0005501_abnormal_skin_physiology | 0.35457276 |
| 112 | MP0004883_abnormal_blood_vessel | 0.35394726 |
| 113 | MP0008438_abnormal_cutaneous_collagen | 0.35243729 |
| 114 | MP0003959_abnormal_lean_body | 0.34811582 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.34498369 |
| 116 | MP0002796_impaired_skin_barrier | 0.33987208 |
| 117 | MP0005187_abnormal_penis_morphology | 0.33629361 |
| 118 | MP0003936_abnormal_reproductive_system | 0.33541855 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.32914872 |
| 120 | MP0003075_altered_response_to | 0.32326859 |
| 121 | MP0003315_abnormal_perineum_morphology | 0.32249302 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.31958140 |
| 123 | MP0003943_abnormal_hepatobiliary_system | 0.31585773 |
| 124 | MP0003283_abnormal_digestive_organ | 0.30847666 |
| 125 | MP0000249_abnormal_blood_vessel | 0.28679102 |
| 126 | MP0002060_abnormal_skin_morphology | 0.26318620 |
| 127 | MP0002822_catalepsy | 0.26231355 |
| 128 | MP0002970_abnormal_white_adipose | 0.26138360 |
| 129 | MP0004147_increased_porphyrin_level | 0.24562261 |
| 130 | MP0001915_intracranial_hemorrhage | 0.24553213 |
| 131 | MP0002135_abnormal_kidney_morphology | 0.24241848 |
| 132 | MP0005023_abnormal_wound_healing | 0.22839033 |
| 133 | MP0005166_decreased_susceptibility_to | 0.22699147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.92982246 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.35644811 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.75649327 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.47415321 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.39134356 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.36127242 |
| 7 | Xanthomatosis (HP:0000991) | 6.24222282 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.42220854 |
| 9 | Joint hemorrhage (HP:0005261) | 4.95064346 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.85852157 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.59513329 |
| 12 | Hyperammonemia (HP:0001987) | 4.56216611 |
| 13 | Complement deficiency (HP:0004431) | 4.47977861 |
| 14 | Ketosis (HP:0001946) | 4.46058498 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40089104 |
| 16 | Hyperglycinemia (HP:0002154) | 4.26169122 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.25422378 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.17001073 |
| 19 | Epidermoid cyst (HP:0200040) | 4.10431922 |
| 20 | Fat malabsorption (HP:0002630) | 4.09161091 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.07622603 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.05722117 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.01429438 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.01429438 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 4.01037203 |
| 26 | Hyperglycinuria (HP:0003108) | 3.98991408 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.90766349 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.86258978 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.74342922 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.60991755 |
| 31 | Hyperbilirubinemia (HP:0002904) | 3.52404689 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.37096552 |
| 33 | Ketoacidosis (HP:0001993) | 3.37034166 |
| 34 | Abnormality of complement system (HP:0005339) | 3.29225161 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23873852 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.19150516 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 3.18247690 |
| 38 | Steatorrhea (HP:0002570) | 3.16090671 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 3.15689639 |
| 40 | Delayed CNS myelination (HP:0002188) | 2.99053554 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.88682077 |
| 42 | Abnormal tarsal ossification (HP:0008369) | 2.87529495 |
| 43 | Spontaneous abortion (HP:0005268) | 2.87407383 |
| 44 | Acanthocytosis (HP:0001927) | 2.87270154 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 2.87156326 |
| 46 | Myocardial infarction (HP:0001658) | 2.81886902 |
| 47 | Oligomenorrhea (HP:0000876) | 2.73878474 |
| 48 | Reduced antithrombin III activity (HP:0001976) | 2.69743158 |
| 49 | Metabolic acidosis (HP:0001942) | 2.69549776 |
| 50 | Hypoglycemic seizures (HP:0002173) | 2.67363332 |
| 51 | Osteomalacia (HP:0002749) | 2.59644547 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.59484964 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59484964 |
| 54 | Abnormal gallbladder morphology (HP:0012437) | 2.56395933 |
| 55 | Skin nodule (HP:0200036) | 2.56198029 |
| 56 | Abnormality of carpal bone ossification (HP:0006257) | 2.55641561 |
| 57 | Spastic diplegia (HP:0001264) | 2.55110288 |
| 58 | Purpura (HP:0000979) | 2.54138287 |
| 59 | Cholelithiasis (HP:0001081) | 2.52659661 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.52527238 |
| 61 | Poikilocytosis (HP:0004447) | 2.52089438 |
| 62 | Late onset (HP:0003584) | 2.51167536 |
| 63 | Flat acetabular roof (HP:0003180) | 2.50609691 |
| 64 | Gout (HP:0001997) | 2.47482733 |
| 65 | Glomerulonephritis (HP:0000099) | 2.45003010 |
| 66 | Vascular calcification (HP:0004934) | 2.44429813 |
| 67 | Esophageal varix (HP:0002040) | 2.40883190 |
| 68 | Lethargy (HP:0001254) | 2.40164724 |
| 69 | Neonatal onset (HP:0003623) | 2.38623441 |
| 70 | Enlarged kidneys (HP:0000105) | 2.38590451 |
| 71 | Mitral stenosis (HP:0001718) | 2.36487261 |
| 72 | Mucopolysacchariduria (HP:0008155) | 2.33663266 |
| 73 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33663266 |
| 74 | Amyloidosis (HP:0011034) | 2.33217215 |
| 75 | Pancreatitis (HP:0001733) | 2.31790330 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.31092969 |
| 77 | Cholecystitis (HP:0001082) | 2.31092969 |
| 78 | Arthropathy (HP:0003040) | 2.28633929 |
| 79 | Cerebral edema (HP:0002181) | 2.24050188 |
| 80 | Thrombophlebitis (HP:0004418) | 2.21908792 |
| 81 | Menorrhagia (HP:0000132) | 2.21606356 |
| 82 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.20232297 |
| 83 | Concave nail (HP:0001598) | 2.19730261 |
| 84 | Systemic lupus erythematosus (HP:0002725) | 2.19575074 |
| 85 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.19453137 |
| 86 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.19453137 |
| 87 | Cardiovascular calcification (HP:0011915) | 2.19350494 |
| 88 | Irritability (HP:0000737) | 2.17356552 |
| 89 | Abnormality of the Achilles tendon (HP:0005109) | 2.16120213 |
| 90 | Malnutrition (HP:0004395) | 2.13898408 |
| 91 | Reticulocytosis (HP:0001923) | 2.13702617 |
| 92 | Hemorrhage of the eye (HP:0011885) | 2.13465227 |
| 93 | Hyperphosphaturia (HP:0003109) | 2.11531061 |
| 94 | Gingival bleeding (HP:0000225) | 2.11002118 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09656101 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09656101 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09656101 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 2.03531061 |
| 99 | Brushfield spots (HP:0001088) | 2.03019238 |
| 100 | Vomiting (HP:0002013) | 2.02556231 |
| 101 | Generalized aminoaciduria (HP:0002909) | 2.02470322 |
| 102 | Abnormality of the gallbladder (HP:0005264) | 2.01003461 |
| 103 | Widely patent fontanelles and sutures (HP:0004492) | 2.00263290 |
| 104 | Increased serum pyruvate (HP:0003542) | 1.97878789 |
| 105 | Abnormality of proline metabolism (HP:0010907) | 1.96101343 |
| 106 | Hydroxyprolinuria (HP:0003080) | 1.96101343 |
| 107 | Hypophosphatemia (HP:0002148) | 1.95373701 |
| 108 | Sparse lateral eyebrow (HP:0005338) | 1.92159113 |
| 109 | Abnormal hand bone ossification (HP:0010660) | 1.91101924 |
| 110 | Abnormal urine phosphate concentration (HP:0012599) | 1.90939712 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.88569111 |
| 112 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88476188 |
| 113 | Hyperglycemia (HP:0003074) | 1.87735670 |
| 114 | Opisthotonus (HP:0002179) | 1.86984352 |
| 115 | Rickets (HP:0002748) | 1.86966682 |
| 116 | Sensorimotor neuropathy (HP:0007141) | 1.84919955 |
| 117 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.83008782 |
| 118 | Elevated alkaline phosphatase (HP:0003155) | 1.81220596 |
| 119 | Hypophosphatemic rickets (HP:0004912) | 1.80920754 |
| 120 | Abnormal ossification of hand bones (HP:0005921) | 1.78809218 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78313653 |
| 122 | Abnormal foot bone ossification (HP:0010675) | 1.78016842 |
| 123 | Bifid scrotum (HP:0000048) | 1.75423085 |
| 124 | Nephritis (HP:0000123) | 1.75136913 |
| 125 | Pulmonary embolism (HP:0002204) | 1.72904345 |
| 126 | Alkalosis (HP:0001948) | 1.72564922 |
| 127 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.71276041 |
| 128 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.71203121 |
| 129 | Gangrene (HP:0100758) | 1.67970233 |
| 130 | Abnormality of glycolysis (HP:0004366) | 1.67956886 |
| 131 | Potter facies (HP:0002009) | 1.65312409 |
| 132 | Facial shape deformation (HP:0011334) | 1.65312409 |
| 133 | Right ventricular cardiomyopathy (HP:0011663) | 1.56733342 |
| 134 | Retinal atrophy (HP:0001105) | 1.52554522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.93740085 |
| 2 | PKN2 | 4.66303712 |
| 3 | SIK1 | 4.54381618 |
| 4 | FGFR4 | 4.31935641 |
| 5 | ERN1 | 3.82852091 |
| 6 | TRIB3 | 3.78112067 |
| 7 | EIF2AK1 | 3.59637645 |
| 8 | CDK12 | 2.98090275 |
| 9 | TAOK3 | 2.71453395 |
| 10 | INSRR | 2.51270962 |
| 11 | FLT3 | 2.50252640 |
| 12 | SCYL2 | 2.38923670 |
| 13 | MAPKAPK3 | 2.21011936 |
| 14 | TSSK6 | 2.20733957 |
| 15 | PTK6 | 2.18577897 |
| 16 | MAP3K10 | 2.14451285 |
| 17 | TESK1 | 2.11588794 |
| 18 | LATS1 | 2.09512356 |
| 19 | MST1R | 1.97192663 |
| 20 | EPHA2 | 1.81750955 |
| 21 | MAP2K4 | 1.71954285 |
| 22 | ERBB4 | 1.65178932 |
| 23 | DAPK2 | 1.61846087 |
| 24 | MAPK11 | 1.55983949 |
| 25 | PIK3CA | 1.51448274 |
| 26 | PIK3CG | 1.44789186 |
| 27 | MUSK | 1.42988929 |
| 28 | CDK7 | 1.39693929 |
| 29 | KDR | 1.35845255 |
| 30 | TYK2 | 1.31469229 |
| 31 | ABL2 | 1.30108155 |
| 32 | RIPK1 | 1.30070730 |
| 33 | NEK9 | 1.23440955 |
| 34 | MET | 1.22399618 |
| 35 | WNK4 | 1.18000189 |
| 36 | GRK6 | 1.13316811 |
| 37 | FGFR2 | 1.08497198 |
| 38 | MAP3K11 | 1.08285012 |
| 39 | MAP2K3 | 1.06154913 |
| 40 | JAK2 | 1.05919287 |
| 41 | LIMK1 | 1.03397710 |
| 42 | PTK2 | 1.01434607 |
| 43 | ERBB2 | 1.00617974 |
| 44 | CDK6 | 1.00413788 |
| 45 | MAP3K7 | 0.98118762 |
| 46 | LMTK2 | 0.93130281 |
| 47 | CDK4 | 0.92977780 |
| 48 | ZAP70 | 0.91922139 |
| 49 | DYRK1B | 0.89201097 |
| 50 | TESK2 | 0.86249830 |
| 51 | MAP3K3 | 0.85189718 |
| 52 | PDGFRA | 0.83239187 |
| 53 | SMG1 | 0.82718645 |
| 54 | EPHB1 | 0.81259426 |
| 55 | PRKAA2 | 0.80730999 |
| 56 | PRKCZ | 0.80443537 |
| 57 | FRK | 0.78039996 |
| 58 | RET | 0.77118188 |
| 59 | TGFBR2 | 0.76744175 |
| 60 | TBK1 | 0.76415933 |
| 61 | EPHA3 | 0.74676405 |
| 62 | TYRO3 | 0.73529665 |
| 63 | TIE1 | 0.73008756 |
| 64 | EIF2AK3 | 0.71767653 |
| 65 | RPS6KB2 | 0.69075800 |
| 66 | MAPK12 | 0.66604313 |
| 67 | MTOR | 0.66555244 |
| 68 | CSK | 0.65930729 |
| 69 | GSK3A | 0.65669180 |
| 70 | MAPK4 | 0.65337786 |
| 71 | PRKACG | 0.65299910 |
| 72 | LRRK2 | 0.60247626 |
| 73 | TAOK2 | 0.59233064 |
| 74 | RPS6KB1 | 0.58813854 |
| 75 | JAK1 | 0.58095237 |
| 76 | CDC42BPA | 0.55037646 |
| 77 | NEK2 | 0.53301925 |
| 78 | ICK | 0.52786145 |
| 79 | CSNK2A2 | 0.52286217 |
| 80 | CSF1R | 0.52270334 |
| 81 | BRSK1 | 0.52024989 |
| 82 | CAMK1D | 0.51472144 |
| 83 | MAP2K1 | 0.51020388 |
| 84 | PRKCI | 0.50574319 |
| 85 | LATS2 | 0.49633064 |
| 86 | STK38L | 0.48535875 |
| 87 | MAP2K2 | 0.48399310 |
| 88 | ALK | 0.48053359 |
| 89 | CSNK1G1 | 0.46663295 |
| 90 | STK38 | 0.46406508 |
| 91 | CSNK1D | 0.46125149 |
| 92 | MAPK15 | 0.45788428 |
| 93 | CAMKK1 | 0.45467664 |
| 94 | EEF2K | 0.45335799 |
| 95 | SGK1 | 0.44071398 |
| 96 | NEK1 | 0.43479248 |
| 97 | FGFR1 | 0.42134140 |
| 98 | PDPK1 | 0.42070940 |
| 99 | PRKG2 | 0.41996076 |
| 100 | PAK2 | 0.41113549 |
| 101 | CSNK2A1 | 0.40885505 |
| 102 | WEE1 | 0.40814502 |
| 103 | EPHA4 | 0.39628857 |
| 104 | SGK494 | 0.38451676 |
| 105 | SGK223 | 0.38451676 |
| 106 | PRKAA1 | 0.38101311 |
| 107 | IGF1R | 0.37963314 |
| 108 | WNK1 | 0.36871862 |
| 109 | SRC | 0.36404873 |
| 110 | EIF2AK2 | 0.36219401 |
| 111 | STK3 | 0.36196200 |
| 112 | MAP3K1 | 0.35465710 |
| 113 | FER | 0.34964093 |
| 114 | TAOK1 | 0.34165665 |
| 115 | PRKG1 | 0.32844734 |
| 116 | PBK | 0.31701585 |
| 117 | PRKCG | 0.31534010 |
| 118 | PINK1 | 0.31519552 |
| 119 | MAP2K6 | 0.30431226 |
| 120 | CAMK1G | 0.29881160 |
| 121 | PDK1 | 0.29737104 |
| 122 | MAPK3 | 0.29560473 |
| 123 | GRK1 | 0.29449739 |
| 124 | MAP3K8 | 0.28517547 |
| 125 | CAMK2G | 0.28108801 |
| 126 | MAP3K12 | 0.27824992 |
| 127 | KSR2 | 0.27610064 |
| 128 | CSNK1E | 0.27444374 |
| 129 | DMPK | 0.27013110 |
| 130 | MAP3K14 | 0.26433666 |
| 131 | SGK3 | 0.26372417 |
| 132 | MAP3K5 | 0.26294248 |
| 133 | MAP3K2 | 0.26170195 |
| 134 | PRKCQ | 0.26010936 |
| 135 | MAPK7 | 0.25687598 |
| 136 | FGFR3 | 0.24665978 |
| 137 | PRKACB | 0.24371204 |
| 138 | CSNK1G2 | 0.23627603 |
| 139 | NTRK1 | 0.22767585 |
| 140 | EPHB2 | 0.22159873 |
| 141 | CSNK1G3 | 0.22080190 |
| 142 | EGFR | 0.21470053 |
| 143 | BMX | 0.21120480 |
| 144 | PAK4 | 0.20704765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.08662809 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.68016957 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.59661248 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.22706771 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98479951 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.78470700 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66255586 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65185143 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64908340 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62138429 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54460880 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45594730 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.31286080 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20742018 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15154927 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96106020 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95997292 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93766860 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93723618 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.88460480 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84833421 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79860386 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.78893006 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77657072 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73734218 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73047870 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71585533 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71297013 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67192530 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66857719 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61984070 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58869051 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57799438 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.55402190 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49966000 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.46420391 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43848344 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41816599 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36847154 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.35820059 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35393064 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34169723 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29974534 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26931524 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25997375 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25977589 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17229890 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15702156 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13159598 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.11147300 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08242626 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07340777 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97680180 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96769496 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.93893438 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93523246 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90483589 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88799329 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.88280912 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78802692 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74644040 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73267715 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72592595 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71739748 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66280045 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58133438 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54355486 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48438754 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42505698 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42488637 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39728238 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26549641 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25356570 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.24173348 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23400097 |
| 76 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22944426 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22400499 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.21681124 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.20166874 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.19716862 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.17449620 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.16653218 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15222960 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15016219 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08979727 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05529192 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00934581 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2470566 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2461834 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2367836 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2347864 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2231208 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2158907 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2097505 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.2053434 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | -0.1908308 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1851581 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1834923 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1426502 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1221822 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1122260 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | -0.1115057 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0866665 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0822237 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0493006 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0381929 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0358027 |
| 108 | Lysosome_Homo sapiens_hsa04142 | -0.0144508 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0001267 |

